Xcout Intel
Sensible Biotechnologies, Inc.
Sensible Biotechnologies, Inc. is an active biotechnology company with operational locations in the United States and Oxfordshire, focusing on advanced molecular innovations. The company is registered with a corporate trust center address in Wilmington, Delaware.
Subscribe to see Sensible Biotechnologies, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Sensible Biotechnologies, Inc. at a glance
Sensible Biotechnologies, Inc. is a company headquartered in United States. Its most recent funding round raised $13.5M in August 2026. Xcout tracks 4 named people at Sensible Biotechnologies, Inc., including Marian Kupculak (Executive Officer).
Sensible Biotechnologies, Inc. leadership
- Marian KupculakExecutive Officer
- Miroslav GasparekExecutive Officer
- Joel SchoppigDirector
- Vishal GulatiDirector
Sensible Biotechnologies, Inc. funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $13.5M | — | |
| Pre-Seed | $4.2M | 7 named | |
| SEC Form D filing | $1.8M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Recent Sensible Biotechnologies, Inc. news
- FundingPrivate placement (Form D)
Investors
Sensible Biotechnologies, Inc. competitors
A few of Sensible Biotechnologies, Inc.'s closest competitors — see the full list of competitors and alternatives →
IdentifySensors Biologics Corp. is a Delaware corporation founded in June 2020 with corporate and facility operations in Texas, focusing on pathogen and biosensing technologies.
Sentrimed, Inc. is a clinical-stage biopharmaceutical company creating safer therapies that has secured federal government contracts and operates with registered locations including Washington, DC.
Converge Bio Inc. is a biotechnology company leveraging generative AI for drug discovery and development, with its corporate registration located in Claymont, Delaware.
Synnovation Therapeutics, Inc. is a Delaware-incorporated biotechnology and holding startup established in 2021 with headquarters at 200 Powder Mill Rd in the United States, focusing on clinical trials and drug discovery.
Syndicate Bio is a biotechnology company headquartered in Delaware that accelerates precision medicine initiatives with a launch rooted out of Nigeria. The company focuses on advancing genomic research and healthcare solutions tailored for diverse populations.
Get Sensible Biotechnologies, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Sensible Biotechnologies, Inc. in Xcout Intel
- 4 named people with titles, LinkedIn and board committees
- 3 funding rounds with the investors in each, and who they co-invest with
- 1 corporate event with sources — deals, leadership changes, layoffs
- The full competitor set, tracking, exports and API access